Short communication · 26 Dec 2025
Conference abstractPublished 22 Oct 2021
Foodborne diseases and emerging technologies; Producing safe food
Vetanco International, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Development of vaccines for effective control of bacterial, viral and protozoal pathogens represents an important development in reducing host morbidity and mortality worldwide. Advancements in the area of biotechnology have increased our innovative potential and allow us to use these technologies to design advanced pathogen control strategies. My laboratory has been working to develop a novel vaccine platform that can provide distinct advantages over traditional classical vaccines. Notably, traditional vaccines tend to be strain or serotype specific and show little or no cross protection to even genetically related strains, our new vaccine technology focuses on creating a single vaccine to protect against multiple serotypes or strains from the same pathogen family by incorporating a single common subunit, produced by bacillus subtilis, into an inactivated orally administered vaccine platform, providing protection against infection and disease by inducing mucosal immunity. This immunity has proved to be protective against families of pathogens regardless of host species; therefore, our platform not only protects against families of pathogens with a single subunit it furthermore protects multiple host species with the same vaccine. Additionally, the platform integrates additional molecules that can train the immune system or reprogram the pathogen favored immune responses that have previously been pre-trained by host-pathogen interactions, driving the immune response toward host favored protection. An additional distinct advantage of this novel platform is the allowance for immunological differentiation of infected from vaccinated host. Which should prove even more important in the face of emerging diseases, such as SARS-CoV-2? Numerous experimental vaccine challenge trials have been conducted to date in multiple host species utilizing this vaccine platform. The platform has shown efficacy and protection (short term and long term) against bacterial, viral and protozoal pathogens alike. Our ultimate goal of creating a single vaccine for multiple hosts against families of pathogens is advancing the “one health” concept towards a tangible reality today.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases & Preventive Medicine.
Opinion · 26 Dec 2025
Challenges in Implementing Preventive Medicine Strategies
Opinion · 24 Dec 2025
The Role of Education in Preventing Infectious Diseases
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases & Preventive Medicine
- SubjectInfectious Diseases
- SubjectPublic Health & Epidemiology
- BylineArticles whose byline prints “Sherryll Layton”
